Connect with us

Cannabis News

New DEA Announcement Shows Desire in Legally Growing Over 3 Million Grams of Marijuana in 2020

David Renfrew



New DEA Announcement Shows Desire in Legally Growing Over 3 Million Grams of Marijuana in 2020
- Ad -
  • The DEA proposed a new quota for cannabis to be grown for research purposes.
  • The public is welcome to comment on this new quota through October 10th.

Research on cannabis has been relatively restrictive in the United States, due to the lack of federal legalization. However, the Drug Enforcement Administration (DEA) has a plan. In a notice published on Thursday, the DEA stated that they want to have 3.2 million grams of marijuana grown legally next year. During this research, the DEA will require over 7,000 pounds of cannabis, allowing them to investigate the effects that it can have.

A recent article in Forbes states that this new proposal is part of the annual quota that the DEA has for the manufacturing of controlled substances. It allows them to “provide for the estimated medical, scientific, research, and industrial needs of the United States, lawful export requirements, and the establishment and maintenance of reserve stocks.” As Forbes pointed out, the amount of marijuana that the DEA plans to have grown in 2020 is over 30% larger than the current year’s quota, which is just under 2.5 million grams.

In a press release, the DEA explained,

“This will meet the need created by the increase in the amount of approved research involving marijuana.”

Through the last two years, the DEA has registered 40% more individuals for research of cannabis, rising from 387 to 542 from 2017 to 2019. Now, the DEA wants to increase those numbers again.

Last month, the agency had explained that they are planning to process new licenses for individuals to manufacture marijuana, even though they initially invited these applications over three years ago. For over 50 years, a single farm at the University of Mississippi has been the legal source of all of the cannabis available to use in research in the United States. However, the scientists performing this research have complained about the quality of the marijuana, as well as how difficult it is to actually procure anything from the farm.

According to the data, the federally approved marijuana that is presently available to researchers is more like hemp than the commercially available marijuana found in dispensaries. Considering this lack of potency, there are many questions regarding how realistic their results could be without using a potency that matches what consumers use.

When asked about this low potency level, the director of the facility stated that he couldn’t understand how any consumer would really want to use cannabis that exceeds 8% THC, which is far lower than what dispensaries offer. However, this is just another sign that his cannabis may not be effective in the research that is being performed.

Public comments are being accepted on this new quota through October 10th, as well as the proposed quotas on THC, LSD, MDMA, and psilocybin being produced in the next year.

David Renfrew is just now beginning his journey at TOC but has found himself on the forefront of the Canadian cannabis culture and marijuana movement. Among being a vocal CBD advocate, Dave is also a politically active father, author, small business owner and fierce reader of fiction and non-fiction. While early, the strong research skills and truly gifted writing talent make David one of our top editors.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.